These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 27178305)
1. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study. Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305 [TBL] [Abstract][Full Text] [Related]
2. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation. Ghaferi M; Asadollahzadeh MJ; Akbarzadeh A; Ebrahimi Shahmabadi H; Alavi SE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952316 [TBL] [Abstract][Full Text] [Related]
5. Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D. Shahbazian S; Akbarzadeh A; Torabi S; Omidi M Biotechnol Lett; 2015 Jul; 37(7):1355-9. PubMed ID: 25792512 [TBL] [Abstract][Full Text] [Related]
6. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin. Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680 [TBL] [Abstract][Full Text] [Related]
7. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells. Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625 [TBL] [Abstract][Full Text] [Related]
8. Cisplatin-loaded albumin nanoparticle and study their internalization effect by using β-cyclodextrin. Tiwari R; Viswanathan K; Gour V; Vyas SP; Soni V J Recept Signal Transduct Res; 2021 Aug; 41(4):393-400. PubMed ID: 32900251 [TBL] [Abstract][Full Text] [Related]
9. Liposomal delivery of organoselenium-cisplatin complex as a novel therapeutic approach for colon cancer therapy. Khabbazian S; Mirhadi E; Gheybi F; Askarizadeh A; Jaafari MR; Alavizadeh SH Colloids Surf B Biointerfaces; 2024 Oct; 242():114085. PubMed ID: 39018910 [TBL] [Abstract][Full Text] [Related]
10. Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy. Toro-Cordova A; Flores-Cruz M; Santoyo-Salazar J; Carrillo-Nava E; Jurado R; Figueroa-Rodriguez PA; Lopez-Sanchez P; Medina LA; Garcia-Lopez P Molecules; 2018 Sep; 23(9):. PubMed ID: 30200551 [TBL] [Abstract][Full Text] [Related]
11. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin. Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366 [TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle. Kai MP; Keeler AW; Perry JL; Reuter KG; Luft JC; O'Neal SK; Zamboni WC; DeSimone JM J Control Release; 2015 Apr; 204():70-7. PubMed ID: 25744827 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study. Bagherpour Doun SK; Alavi SE; Koohi Moftakhari Esfahani M; Ebrahimi Shahmabadi H; Alavi F; Hamzei S Tumour Biol; 2014 Aug; 35(8):7491-7. PubMed ID: 24789433 [TBL] [Abstract][Full Text] [Related]
15. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. Wang F; Chen L; Zhang R; Chen Z; Zhu L J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829 [TBL] [Abstract][Full Text] [Related]
16. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585 [TBL] [Abstract][Full Text] [Related]
17. Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells. Kanaani L; Javadi I; Ebrahimifar M; Ebrahimi Shahmabadi H; Akbarzadeh Khiyav A; Mehrdiba T Asian Pac J Cancer Prev; 2017 Feb; 18(2):365-368. PubMed ID: 28345332 [TBL] [Abstract][Full Text] [Related]
18. Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma. Belletti D; Tosi G; Riva G; Lagreca I; Galliania M; Luppi M; Vandelli MA; Forni F; Ruozi B Int J Pharm; 2015 Jul; 490(1-2):85-93. PubMed ID: 25987470 [TBL] [Abstract][Full Text] [Related]
19. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer. Sultan MH; Moni SS; Madkhali OA; Bakkari MA; Alshahrani S; Alqahtani SS; Alhakamy NA; Mohan S; Ghazwani M; Bukhary HA; Almoshari Y; Salawi A; Alshamrani M Sci Rep; 2022 Jan; 12(1):468. PubMed ID: 35013493 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas. Hwang TL; Lee WR; Hua SC; Fang JY J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]